Skip to content

Randomized, Double-blind, Controlled Trial of Jinqi Jiangtang Tablet Intervention on Pre-diabetes

The study of evidence based medicine for jinqi jiangtang tablet intervention on pre-diabetes

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-PRC-09000401
Enrollment
Unknown
Registered
2009-05-08
Start date
2009-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pre-diabetes

Interventions

treatment group:Jin qi jiang tang pill
control group:simulated agents

Sponsors

Tianjin University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) to be diagnosed by the pre-diabetes diagnostic criteria; 2) to be diagnosed by the TCM diagnostic criteria; 3) To be aged from 18 to 75 yeas; 4) Signed Informed Consent Form.

Exclusion criteria

Exclusion criteria: 1) a history of diabetes (except gestational diabetes); 2) cardiovascular events in the near future; a) have cerebrovascular accident in 6 months, history of myocardial infarction or heart failure; b) severe organic heart disease; c) aneurysm with the main artery or dissecting aneurysm; d) specific angina, II degrees atrioventricular block, sick sinus syndrome; 3) impaired hepatic and renal function: AST and / or ALT above 2 times the upper limit of normal. creatinine above 2 times the upper limit of normal. Urine protein> ++ and / or hematuria; 4) triglycerides in empty stomach >=10 mmol/L; 5) endocrine disease such as hyperthyroidism, autoallergic disease, cancer or any serious fatal illness; 6) use of glucocorticoid, beta receptor blockers, Thiazide diuretics, nicotinic acid and other drugs; 7) pregnancy, preparation of pregnancy and lactating women; 8) suffering from mental diseases, no insight, can not exact expression; or patients couldn't cooperate with instructions (with the diet control, or medicine taking without follow requirement); 9) Having taken or being taking other clinical trial within two weeks; 10) Allergic constitution.

Design outcomes

Primary

MeasureTime frame
Evaluation criteria of efficacy on diabetes conversion;The rate of blood glucose return to normal;

Secondary

MeasureTime frame
Evaluation of TCM symptom score?efficacy evaluation of synthesis symptom;The rate of blood glucose return to normal;

Countries

China

Contacts

Public ContactLiping guo
caohongboebm@foxmail.coml+86 0 13821806546

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 15, 2026